Electroencephalography (EEG) slowing with prealpha dominant frequency (DF) in posterior
derivations is a biomarker for dementia with Lewy bodies (DLB) diagnosis, in contrast with …

Objective Here we tested if cortical sources of resting state electroencephalographic (rsEEG)
rhythms may differ in sub-groups of patients with prodromal and overt dementia with Lewy …

Quantitative EEG (QEEG) has demonstrated good discriminative capacity for dementia with
Lewy bodies (DLB) diagnosis as compared to Alzheimer's disease (AD) with a predictive …

Despite improvements in diagnostic criteria for dementia with Lewy bodies (DLB), the ability
to discriminate DLB from Alzheimer's disease (AD) and other dementias remains …

Abstract Background/Aim: Dementia with Lewy bodies (DLB) is probably still
underdiagnosed in the clinical setting. Previous studies have suggested a relationship …

Mild cognitive impairment (MCI) as a precursor of dementia with Lewy bodies (DLB) is the
focus of recent research, trying to explore the early mechanisms and possible biomarkers of …

Objective We investigated for quantitative EEG (QEEG) differences between Alzheimer's
disease (AD), dementia with Lewy bodies (DLB) and Parkinson's disease dementia (PDD) …

Dementia with Lewy bodies (DLB) and Alzheimer's disease (AD) require differential
management despite presenting with symptomatic overlap. Currently, there is a need of …

Background: Prodromal dementia with Lewy bodies (DLB) can emerge with the onset of mild
cognitive impairment (MCI). Standard biomarkers can help identify such patients to improve …

Introduction: Previous studies on electroencephalography (EEG) to discriminate between
dementia with Lewy bodies (DLB) and Alzheimer's disease (AD) have been promising …